BillionToOne’s Pioneering Study Demonstrates 100% Accuracy for Non-Invasive Fetal RhD Detection in US Population
Peer reviewed research published in Green Journal shows BillionToOne's NGS technology excels in testing diverse US populations BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced today the groundbreaking results from a recent large US-based clinical study demonstrating 100% accuracy in its non-invasive prenatal […]